PPD Names VPs for North America and Asia( Expands global senior leadership...),Health

Expands global senior leadership team; restructures business units

geographically

WILMINGTON, N.C., Oct. 10 /PRNewswire-FirstCall/ -- PPD, Inc. (Nasdaq: PPDI) today announced the appointments of Paul D. Colvin as senior vice president of clinical operations for North America and Simon J. Britton as vice president of clinical operations for Asia.

Mr. Colvin joins PPD from Eli Lilly and Company where he most recently directed clinical operations and global patient enrollment optimization. During his 14-year career at Lilly, he held a series of leadership positions including chief operations officer for the global cardiovascular brand team; European clinical operations senior manager for the oncology, critical care, primary care and neuroscience business units; global clinical operations manager for oncology project teams; and clinical project management leader for the oncology project team.

"Paul Colvin brings extensive global development experience across a wide range of therapeutic areas garnered during an impressive tenure with Lilly," said William Sharbaugh, chief operating officer of PPD. "His experience as a leader in the trenches of clinical drug development will serve him well in overseeing our North American Phase II-IV operational unit."

The position assumed by Mr. Britton is a new senior management role created specifically for the company's business on that continent.

"With Asia's escalating importance to global drug development, additional leadership will enable us to drive PPD's continued growth in the region," Mr. Sharbaugh said. "We are pleased to gain Simon Britton as a member of our team with his comprehensive international experience and proven ability to expand business scope and deliver quality results."

Mr. Britton spent the last seven years at GlaxoSmithKline where he most recently served as head of international clinical operations, managing the company's global clini
'/>"/>